<DOC>
	<DOCNO>NCT02632851</DOCNO>
	<brief_summary>This observational , non-interventional multicentric study compare inhalation therapy patient suffer respiratory tract infection and/or acute bronchitis Ectoin inhalation solution Pari NaCl ( 0.9 % ) inhalation solution</brief_summary>
	<brief_title>Treatment Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution</brief_title>
	<detailed_description>The assessment focus bronchitis Severity Score ( BSS ) standardize use clinical study outcome criterion cough , sputum production , rales/rhonchi , chest pain coughing dysnoea</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>accord instruction use accord instruction use</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>inhalation</keyword>
	<keyword>isotonic saline</keyword>
	<keyword>NaCl solution 0.9 %</keyword>
	<keyword>Ectoin</keyword>
	<keyword>bronchitis</keyword>
	<keyword>respiratory tract infection</keyword>
</DOC>